Progenitor Labs Raises $5.8M for Adult Stem Cell Work
Progenitor Labs Ltd. has raised £4 million (US$5.8 million) in seed financing from the GlaxoSmithKline plc venture fund SR One, enabling the company to further develop its platform technology for screening for small molecules that promote the differentiation of endogenous adult stem cells.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter